Abstract
Nanotechnology is a broad term that encompasses materials, structures, or processes that utilize engineered nanomaterials, which can be defined as materials intentionally designed to have one or more dimensions between 1 and 100 nm. Historically, risk characterization has been viewed as the final phase of a risk assessment process that integrates hazard identification, dose-response assessment, and exposure assessment. The novelty and diversity of materials, structures, and tools that are covered by above-defined "nanotechnology" raise substantial methodological issues and pose significant challenges for each of these phases of risk assessment. These issues and challenges culminate in the risk characterization phase of the risk assessment process, and this article discusses several of these key issues and approaches to developing risk characterization results and their implications for risk management decision making that are specific to nanotechnology.
Original language | English (US) |
---|---|
Pages (from-to) | 1671-1679 |
Number of pages | 9 |
Journal | Risk Analysis |
Volume | 30 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2010 |
Externally published | Yes |
Keywords
- Nanotechnology
- Risk
- Risk assessment
- Risk characterization
- Risk management
- Risk-benefit tradeoff
ASJC Scopus subject areas
- Safety, Risk, Reliability and Quality
- Physiology (medical)